Close
Day Lab research programme has led to significant research outputs of sustained quality, including UCL's first biomaterial for tissue regeneration granted approval for clinical use by the Medicines and Healthcare Products Regulatory Agency and associated first-in-human phase I/II clinical trial. The technology is backed by a portfolio of patent families, industry collaborations and licencing agreements.
- The core areas of research are:
- Bowel & Bladder Health
- Cardiovascular Disease
- Cell Delivery
- Characterizing the Immune Response
- Combating Antimicrobial Resistance
- Drug Delivery
- Immunotherapy
- Magnetic Actuation
- TIPS Microspheres